Oxbridge Clinical is creating innovative technologies for point-of-care, germ-specific diagnosis and antibiograms.
Oxbridge Clinical has raised $4.5M in total funding. The most recent round was Seed. The last funding was announced in October 2025.
Oxbridge Clinical's investors include BioTools Innovator.
Oxbridge Clinical is headquartered in Boston, United States.
Oxbridge Clinical is creating innovative technologies for point-of-care, germ-specific diagnosis and antibiograms.
Oxbridge Clinical is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oxbridge Clinical — Funding & Investors." VCBacked, October 31, 2025, https://www.vcbacked.co/company/oxbridge-clinical. Accessed September 30, 2026.
VCBacked. (2025). Oxbridge Clinical — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/oxbridge-clinical
{{cite web |title=Oxbridge Clinical — Funding & Investors |url=https://www.vcbacked.co/company/oxbridge-clinical |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated